Iceland Press Releases

Published on February 9, 2023 - 07:48 GMT

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) BAD VILBEL, HESSEN, GERMANY, February 9, 2023 /⁨EINPresswire.com⁩/ -- EMA Confirms Acceptance of …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 9, 2023 - 07:30 GMT

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) EMA opinion on AVT04 could come as soon as the second half of 2023 Reference product Stelara® (ustekinumab …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 6, 2023 - 09:00 GMT

Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia, and New Zealand REYKJAVIK, Iceland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global …

Distribution channels: Companies, Technology ...

Published on January 24, 2023 - 09:00 GMT

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Bioventure, a wholly …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 23, 2023 - 08:24 GMT

Alvotech Completes $137 Million Private Share Placement

REYKJAVIK, Iceland, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement of …

Distribution channels: Technology

Published on January 16, 2023 - 14:19 GMT

Craft Beer Marketing Awards Announces New Tattoo Category for Charity

Proceeds of global competition's new category to benefit The Michael James Jackson Foundation to fund scholarships for people of color entering brewing industry MELVILLE, NEW YORK, USA, January 16, 2023 /⁨EINPresswire.com⁩/ -- In the spirit of giving …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on January 13, 2023 - 09:00 GMT

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate

REYKJAVIK, Iceland and TOKYO, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji …

Distribution channels: Companies, Technology ...

Published on January 11, 2023 - 09:00 GMT

Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today the initiation of a pharmacokinetic …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 10, 2023 - 13:15 GMT

New Emergency Department Study Shows NeurOptics’ Neurological Pupil Index™ is Unaffected by Clinical Intoxication

Results show Automated Pupillometer and NPi® can be used for patient evaluation and triage without risk of confounding by key intoxicants of abuse IRVINE, CALIF., USA, January 10, 2023 /⁨EINPresswire.com⁩/ -- A newly published clinical study shows that …

Distribution channels: Culture, Society & Lifestyle, Electronics Industry ...

Published on January 6, 2023 - 09:00 GMT

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (...

The U.S. Food and Drug Administration’s (FDA) regulatory review is anticipated to be completed in the second half of 2023 Stelara® (ustekinumab) is prescribed to treat a variety of inflammatory conditions REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 06, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on December 22, 2022 - 09:00 GMT

Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira®

U.S. Food and Drug Administration (FDA) has confirmed that the goal date for an approval decision on Alvotech’s license application for AVT02 is April 13, 2023 FDA has completed review of Alvotech’s application of AVT02 as an interchangeable to high- …

Distribution channels: Technology

Published on December 16, 2022 - 11:45 GMT

Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field

Reference is made to the announcement issued earlier today about the completion of a private placement of subordinated convertible bonds. The aggregate principal amount is approximately US$70 million, instead of US$59.7 million. Please see correction below …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 16, 2022 - 09:00 GMT

Alvotech Completes $59.7 Million Private Placement

REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 14, 2022 - 14:00 GMT

Big Innovation in Sustainable Clothing Made Possible With Insulation From Icelandic Wool Fabric

REYKJAVÍK, Iceland, Dec. 14, 2022 (GLOBE NEWSWIRE) -- It was the end of 2021 when Icewear announced its greatest innovation after almost 50 years in business. In partnership with Ístex, Icewear launched a new outdoor line with unique and sustainable …

Distribution channels:

Published on December 13, 2022 - 13:45 GMT

NeurOptics Neurological Pupil index & Automated Pupillometry Included in European Guidelines for Post-Resuscitation Care

The Neurological Pupil index™ (NPi®) and automated NPi pupillometry globally emerging as important for use in patients following cardiac arrest IRVINE, CALIFORNIA, USA, December 13, 2022 /⁨EINPresswire.com⁩/ -- NeurOptics’ Neurological Pupil index™ (NPi …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on December 12, 2022 - 11:36 GMT

Sofokus Ventures launches Digital Heart Capital II startup investment company

Sofokus, a digital business expert group, founded an investment company Digital Heart Capital II for early-stage startups with digital core solutions. TURKU, FINLAND, December 12, 2022 /⁨EINPresswire.com⁩/ -- Sofokus, a digital business expert group from …

Distribution channels: Agriculture, Farming & Forestry Industry, Automotive Industry ...

Published on December 10, 2022 - 14:00 GMT

How Hikers Gain Natural Protection With Icewear's Unique New Icelandic Sheep Wool Insulation

REYKJAVÍK, Iceland, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Iceland has been a popular tourist destination for generations, and the reasons are as diverse as the tourists. Iceland is patently scenic. Most Icelandic landscapes are uninterrupted by cities (or …

Distribution channels:

Published on December 8, 2022 - 08:30 GMT

Alvotech Shares Start Trading on Nasdaq Iceland Main Market

Robert Wessman Founder and Executive Chairman will ring the Nasdaq Iceland closing bell at 15:30 GMT on December 8, 2022 Listing on the Main Market can increase visibility, which may allow the company to appear in both domestic and global indexes Alvotech …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 7, 2022 - 09:00 GMT

Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe

Hukyndra® (adalimumab) launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe Follows initial introduction of Hukyndra in nine countries: …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 1, 2022 - 14:15 GMT

Noxilizer NO₂ sterilization used by global pharma and biotech companies on products submitted for regulatory approval

Demand for NO₂ sterilization expands for pharma, biotech, and medical device customers HANOVER, MD, UNITED STATES, December 1, 2022 /⁨EINPresswire.com⁩/ -- Noxilizer announces that multiple pharmaceutical and biotech companies have completed or are in …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Iceland Press Releases Distributed by EIN Presswire